BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24781949)

  • 1. Downregulation of ABCG2 protein inhibits migration and invasion in U251 glioma stem cells.
    Gong W; Wang Z; Wan Y; Shi L; Zhou Y
    Neuroreport; 2014 May; 25(8):625-32. PubMed ID: 24781949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2.
    Shi L; Wang Z; Sun G; Wan Y; Guo J; Fu X
    Neuromolecular Med; 2014 Jun; 16(2):517-28. PubMed ID: 24777293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and significance of ABCG2 in human malignant glioma].
    Chu L; Huang Q; Zhai DZ; Zhu Q; Huo HM; Dong J; Qian ZY; Wang AD; Lan Q; Gao YL
    Ai Zheng; 2007 Oct; 26(10):1090-4. PubMed ID: 17927879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ABCG2 transporter is a key molecular determinant of the efficacy of sonodynamic therapy with Photofrin in glioma stem-like cells.
    Xu ZY; Wang K; Li XQ; Chen S; Deng JM; Cheng Y; Wang ZG
    Ultrasonics; 2013 Jan; 53(1):232-8. PubMed ID: 22771084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCG2 downregulation in glioma stem cells enhances the therapeutic efficacy of demethoxycurcumin.
    Chen L; Shi L; Wang W; Zhou Y
    Oncotarget; 2017 Jun; 8(26):43237-43247. PubMed ID: 28591733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Nrf2 in migration and invasion of human glioma cell U251.
    Pan H; Wang H; Zhu L; Mao L; Qiao L; Su X
    World Neurosurg; 2013; 80(3-4):363-70. PubMed ID: 22120303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.
    Ding XW; Wu JH; Jiang CP
    Life Sci; 2010 Apr; 86(17-18):631-7. PubMed ID: 20159023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
    Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS
    Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin enhances the invasive ability of glioma stem-like cells depending on leptin receptor expression.
    Han G; Zhao W; Wang L; Yue Z; Zhao R; Li Y; Zhou X; Hu X; Liu J
    Brain Res; 2014 Jan; 1543():1-8. PubMed ID: 24161825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a side population of astrocytoma cells in response to temozolomide.
    Chua C; Zaiden N; Chong KH; See SJ; Wong MC; Ang BT; Tang C
    J Neurosurg; 2008 Nov; 109(5):856-66. PubMed ID: 18976075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ultrastructural difference between CD133-positive U251 glioma stem cells and normal U251 glioma cells.
    Yang B; Wang Y; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
    Ultrastruct Pathol; 2012 Dec; 36(6):404-8. PubMed ID: 23216238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2.
    Liu B; Guo Z; Dong H; Daofeng T; Cai Q; Ji B; Zhang S; Wu L; Wang J; Wang L; Zhu X; Liu Y; Chen Q
    Brain Res; 2015 Jun; 1611():93-100. PubMed ID: 25801120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells.
    Shen WW; Zeng Z; Zhu WX; Fu GH
    J Mol Med (Berl); 2013 Aug; 91(8):989-1000. PubMed ID: 23619912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioma stem-like cells are less susceptible than glioma cells to sonodynamic therapy with photofrin.
    Xu ZY; Li XQ; Chen S; Cheng Y; Deng JM; Wang ZG
    Technol Cancer Res Treat; 2012 Dec; 11(6):615-23. PubMed ID: 22775340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of CD133+ cancer stem-like cells in endometrial cancer.
    Nakamura M; Zhang X; Mizumoto Y; Maida Y; Bono Y; Takakura M; Kyo S
    Int J Oncol; 2014 Mar; 44(3):669-77. PubMed ID: 24366104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2.
    Wang Z; Wang B; Shi Y; Xu C; Xiao HL; Ma LN; Xu SL; Yang L; Wang QL; Dang WQ; Cui W; Yu SC; Ping YF; Cui YH; Kung HF; Qian C; Zhang X; Bian XW
    Oncogene; 2015 Mar; 34(11):1407-19. PubMed ID: 24704830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine.
    Zhang FY; Hu Y; Que ZY; Wang P; Liu YH; Wang ZH; Xue YX
    Int J Mol Sci; 2015 Oct; 16(10):23823-48. PubMed ID: 26473829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-328 is a favorable prognostic marker in human glioma via suppressing invasive and proliferative phenotypes of malignant cells.
    Yuan J; Zheng Z; Zheng Y; Lu X; Xu L; Lin L
    Int J Neurosci; 2016; 126(2):145-53. PubMed ID: 25562367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation.
    Ouyang WC; Liao YW; Chen PN; Lu KH; Yu CC; Hsieh PL
    Cancer Chemother Pharmacol; 2017 Aug; 80(2):411-419. PubMed ID: 28685346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
    Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
    Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.